Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04557449
Phase: PHASE1|PHASE2
Trial Summary: This is a Phase 1/2A, open label, multicenter, nonrandomized, multiple dose, safety, tolerability, pharmacokinetic and pharmacodynamic study of PF-07220060 administered as a single – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Pfizer
Acronym: CDK4i

Pin It on Pinterest